{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:42:24Z","timestamp":1792510944089,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.clinph.2020.02.028","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T19:33:29Z","timestamp":1585856009000},"page":"1979-1985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Electrophysiological and phenotypic profiles of taxane-induced neuropathy"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5504-1625","authenticated-orcid":false,"given":"Hannah C.","family":"Timmins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Baron-Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna B.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinph.2020.02.028_b0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdt409","article-title":"Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin","volume":"25","author":"Alberti","year":"2014","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.clinph.2020.02.028_b0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2008.01.008","article-title":"Peripheral nerve damage associated with administration of taxanes in patients with cancer","volume":"66","author":"Argyriou","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clinph.2020.02.028_b0015","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2019-320969","article-title":"Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings","author":"Argyriou","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.clinph.2020.02.028_b0020","first-page":"647","article-title":"Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?","volume":"13","author":"Argyriou","year":"2005","journal-title":"Supportive Care Cancer"},{"issue":"2","key":"10.1016\/j.clinph.2020.02.028_b0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.282.2.153","article-title":"Prevalence of carpal tunnel syndrome in a general population","volume":"282","author":"Atroshi","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clinph.2020.02.028_b0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11060-007-9438-8","article-title":"Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings","volume":"86","author":"Augusto","year":"2008","journal-title":"J Neurooncol"},{"issue":"11","key":"10.1016\/j.clinph.2020.02.028_b0035","first-page":"2959","article-title":"Impact of oxaliplatin-induced neuropathy: a patient perspective","volume":"20","author":"Bennett","year":"2012","journal-title":"Supportive Care Cancer"},{"issue":"8","key":"10.1016\/j.clinph.2020.02.028_b0040","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/1097-4598(200008)23:8<1280::AID-MUS20>3.0.CO;2-Y","article-title":"A neurophysiological grading scale for carpal tunnel syndrome","volume":"23","author":"Bland","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2020.02.028_b0045","first-page":"35","article-title":"Hand related disorders following axillary dissection for breast cancer","volume":"14","author":"Bozentka","year":"2001","journal-title":"Uni Pennsylvania Orthop J"},{"issue":"3","key":"10.1016\/j.clinph.2020.02.028_b0050","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/mus.880160304","article-title":"Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders","volume":"16","author":"Bromberg","year":"1993","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.clinph.2020.02.028_b0055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jnnp.37.6.647","article-title":"Sensory conduction of the sural nerve in polyneuropathy","volume":"37","author":"Burke","year":"1974","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinph.2020.02.028_b0060","first-page":"221","article-title":"Delayed radiation-induced damage to the brachial plexus","volume":"15","author":"Burns","year":"1978","journal-title":"Clin Exp Neurol"},{"issue":"6","key":"10.1016\/j.clinph.2020.02.028_b0065","first-page":"741","article-title":"Psychometric evaluation of the functional assessment of cancer therapy\/gynecologic oncology group-neurotoxicity (Fact\/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy","volume":"13","author":"Calhoun","year":"2003","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.clinph.2020.02.028_b0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1085-9489.2006.00078.x","article-title":"Multi-center assessment of the total neuropathy score for chemotherapy-induced peripheral neurotoxicity","volume":"11","author":"Cavaletti","year":"2006","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"10.1016\/j.clinph.2020.02.028_b0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/mus.25203","article-title":"Electrodiagnostic reference values for upper and lower limb nerve conduction studies in adult populations","volume":"54","author":"Chen","year":"2016","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.clinph.2020.02.028_b0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/WNP.0b013e3182767d3b","article-title":"Electrophysiological features of taxane-induced polyneuropathy in patients with breast cancer","volume":"30","author":"Chen","year":"2013","journal-title":"J Clin Neurophysiol"},{"issue":"8","key":"10.1016\/j.clinph.2020.02.028_b0085","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.53.8.1660","article-title":"Total neuropathy score: validation and reliability study","volume":"53","author":"Cornblath","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clinph.2020.02.028_b0090","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0895-4356(92)90038-O","article-title":"Carpal tunnel syndrome: prevalence in the general population","volume":"45","author":"de Krom","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.clinph.2020.02.028_b0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.radonc.2012.10.012","article-title":"Radiation-induced neuropathy in cancer survivors","volume":"105","author":"Delanian","year":"2012","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.clinph.2020.02.028_b0100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.clbc.2018.02.003","article-title":"Chemotherapy dose intensity and overall survival among patients with advanced breast or ovarian cancer","volume":"18","author":"Denduluri","year":"2018","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1016\/j.clinph.2020.02.028_b0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","article-title":"Distal symmetric polyneuropathy: A definition for clinical research","volume":"64","author":"England","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.clinph.2020.02.028_b0110","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/rheumatology\/37.6.630","article-title":"Estimating the prevalence of delayed median nerve conduction in the general population","volume":"37","author":"Ferry","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"6","key":"10.1016\/j.clinph.2020.02.028_b0115","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1590\/S1413-35552012005000062","article-title":"Intra-observer reproducibility of the feet soles two-point discrimination test in asymptomatic elderly and young individuals","volume":"16","author":"Franco","year":"2012","journal-title":"Rev Bras Fisioter"},{"key":"10.1016\/j.clinph.2020.02.028_b0120","doi-asserted-by":"crossref","unstructured":"Ganel A, Engel J, Sela M, Brooks M. Nerve entrapments associated with postmastectomy lymphedema. Cancer. 1979;44(6):2254\u20139.10.1002\/1097-0142(197912)44:6<2254::aid-cncr2820440638>3.0.co;2-9.","DOI":"10.1002\/1097-0142(197912)44:6<2254::AID-CNCR2820440638>3.0.CO;2-9"},{"issue":"3","key":"10.1016\/j.clinph.2020.02.028_b0125","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10549-010-1278-0","article-title":"Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy","volume":"125","author":"Hershman","year":"2011","journal-title":"Breast Cancer Res Tr"},{"key":"10.1016\/j.clinph.2020.02.028_b0130","unstructured":"Jemal A, Torre L, Soerjomataram I, Bray F. In: Daniel J, editor. The cancer atlas. 3rd ed. Atlanta, GA: American Cancer Society; 2019."},{"key":"10.1016\/j.clinph.2020.02.028_b0135","first-page":"75","article-title":"Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer","volume":"1166","author":"Kandula","year":"2017","journal-title":"Clin Neurophysiol"},{"issue":"5","key":"10.1016\/j.clinph.2020.02.028_b0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00002018-200023050-00005","article-title":"Risks and benefits of taxanes in breast and ovarian cancer","volume":"23","author":"Michaud","year":"2000","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.clinph.2020.02.028_b0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.46.1.108","article-title":"Peripheral neuropathy secondary to docetaxel (Taxotere)","volume":"46","author":"New","year":"1996","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clinph.2020.02.028_b0150","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3816\/CBC.2008.n.043","article-title":"Carpal tunnel syndrome associated with the use of aromatase inhibitors in breast cancer","volume":"8","author":"Nishihori","year":"2008","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1016\/j.clinph.2020.02.028_b0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF01999566","article-title":"Paclitaxel neurotoxicity: clinical and neurophysiological study of 23 patients","volume":"18","author":"Pace","year":"1997","journal-title":"Ital J Neurol Sci"},{"issue":"12","key":"10.1016\/j.clinph.2020.02.028_b0160","first-page":"5059","article-title":"Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)","volume":"24","author":"Pachman","year":"2016","journal-title":"Supportive Care Cancer"},{"issue":"6","key":"10.1016\/j.clinph.2020.02.028_b0165","first-page":"419","article-title":"Chemotherapy-induced peripheral neurotoxicity: a critical analysis","volume":"63","author":"Park","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.clinph.2020.02.028_b0170","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2010-0248","article-title":"Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility","volume":"16","author":"Park","year":"2011","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.clinph.2020.02.028_b0175","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/PRS.0000000000004839","article-title":"Validity of the tinel sign and prevalence of tibial nerve entrapment at the tarsal tunnel in both diabetic and nondiabetic subjects: a cross-sectional study","volume":"142","author":"Rinkel","year":"2018","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.clinph.2020.02.028_b0180","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values","volume":"123","author":"Rolke","year":"2006","journal-title":"Pain"},{"issue":"17","key":"10.1016\/j.clinph.2020.02.028_b0185","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4239\/wjd.v7.i17.342","article-title":"Entrapment neuropathies in diabetes mellitus","volume":"7","author":"Rota","year":"2016","journal-title":"World J Diabetes"},{"key":"10.1016\/j.clinph.2020.02.028_b0190","first-page":"107","article-title":"Neurotoxicity of taxol","volume":"15","author":"Rowinsky","year":"1993","journal-title":"J Natl Cancer Inst Monographs"},{"key":"10.1016\/j.clinph.2020.02.028_b0195","doi-asserted-by":"crossref","unstructured":"Rutkove SB, Kothari MJ, Raynor EM, Levy ML, Fadic R, Nardin RA. Sural\/radial amplitude ratio in the diagnosis of mild axonal polyneuropathy. Muscle Nerve. 1997;20(10):1236-41.10.1002\/(sici)1097-4598(199710)20:10<1236::Aid-mus5>3.0.Co;2-d.","DOI":"10.1002\/(SICI)1097-4598(199710)20:10<1236::AID-MUS5>3.3.CO;2-P"},{"issue":"7","key":"10.1016\/j.clinph.2020.02.028_b0200","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archneur.1994.00540190110024","article-title":"Taxol neuropathy: electrodiagnostic and sural nerve biopsy findings","volume":"51","author":"Sahenk","year":"1994","journal-title":"Arch Neurol"},{"issue":"30","key":"10.1016\/j.clinph.2020.02.028_b0205","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1200\/JCO.2009.22.0236","article-title":"Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial","volume":"27","author":"Sestak","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clinph.2020.02.028_b0210","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10549-019-05270-4","article-title":"Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy","volume":"176","author":"Sheng","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.clinph.2020.02.028_b0215","series-title":"Practical approach to electromyography: an illustrated guide for clinicians","author":"Siao","year":"2011"},{"issue":"2","key":"10.1016\/j.clinph.2020.02.028_b0220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/WNP.0000000000000352","article-title":"Investigation of nerve conduction studies of carpal tunnel syndrome cases with different risk factors: an electrodiagnostic study","volume":"34","author":"Solmaz","year":"2017","journal-title":"J Clin Neurophysiol"},{"issue":"6","key":"10.1016\/j.clinph.2020.02.028_b0225","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00280-016-3190-8","article-title":"Aromatase inhibitor-induced carpal tunnel syndrome: prevalence in daily practice","volume":"78","author":"Soumaya","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clinph.2020.02.028_b0230","doi-asserted-by":"crossref","unstructured":"Stevens JC. AAEM minimonograph #26: The electrodiagnosis of carpal tunnel syndrome. Muscle Nerve. 1997;20(12):1477-86.10.1002\/(sici)1097-4598(199712)20:12<1477::Aid-mus1>3.0.Co;2-5.","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1477::AID-MUS1>3.0.CO;2-5"},{"issue":"6","key":"10.1016\/j.clinph.2020.02.028_b0235","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/mus.24506","article-title":"Carpal tunnel syndrome in breast cancer survivors with upper extremity lymphedema","volume":"51","author":"Stubblefield","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2020.02.028_b0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual Life Outcomes"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245720301097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245720301097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:58:24Z","timestamp":1761393504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245720301097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1388245720301097"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2020.02.028","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrophysiological and phenotypic profiles of taxane-induced neuropathy","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2020.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}